|
End-of-day quote
NSE India S.E.
2026-10-19
|
5-day change | 1st Jan Change | ||
| 1,766.60 INR | -2.97% |
|
-5.40% | +29.47% |
Company Valuation: Emcure Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 203,202 | 302,490 | 335,089 | - | - |
| Change | - | 48.86% | 10.78% | - | - |
| Enterprise Value (EV) 1 | 208,106 | 306,160 | 341,473 | 331,811 | 319,591 |
| Change | - | 47.12% | 11.53% | -2.83% | -3.68% |
| P/E | 29.4x | 32.7x | 28.2x | 23x | 19x |
| PBR | 4.57x | - | 5.5x | 4.49x | 3.67x |
| PEG | - | 1x | 1x | 1x | 0.9x |
| Capitalization / Revenue | 2.57x | 3.29x | 3.16x | 2.8x | 2.5x |
| EV / Revenue | 2.64x | 3.33x | 3.22x | 2.78x | 2.39x |
| EV / EBITDA | 14.2x | 17.1x | 15.8x | 13.1x | 11x |
| EV / EBIT | 19.2x | 22.3x | 20.2x | 16.3x | 13.3x |
| EV / FCF | 33x | 52.5x | 34.5x | 28.1x | 21.4x |
| FCF Yield | 3.03% | 1.9% | 2.9% | 3.56% | 4.66% |
| Dividend per Share 2 | 3 | 3.6 | 4.007 | 4.728 | 5.773 |
| Rate of return | 0.28% | 0.23% | 0.23% | 0.27% | 0.33% |
| EPS 2 | 36.43 | 48.77 | 62.72 | 76.87 | 92.93 |
| Distribution rate | 8.23% | 7.38% | 6.39% | 6.15% | 6.21% |
| Net sales 1 | 78,960 | 92,035 | 106,051 | 119,492 | 133,996 |
| EBITDA 1 | 14,689 | 17,890 | 21,618 | 25,273 | 29,101 |
| EBIT 1 | 10,847 | 13,740 | 16,908 | 20,318 | 24,113 |
| Net income 1 | 6,813 | 9,244 | 11,895 | 14,545 | 17,577 |
| Net Debt 1 | 4,904 | 3,670 | 6,384 | -3,278 | -15,498 |
| Reference price 2 | 1,072.40 | 1,595.50 | 1,766.60 | 1,766.60 | 1,766.60 |
| Nbr of stocks (in thousands) | 189,483 | 189,590 | 189,680 | - | - |
| Announcement Date | 5/22/25 | 5/5/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.03x | 3.32x | 16.27x | 0.22% | 3.64B | ||
| 35.96x | 12.96x | 27.14x | 0.55% | 1,120B | ||
| 37.4x | 6.3x | 17.74x | 2.09% | 616B | ||
| 36.43x | 8.36x | 17.24x | 2.43% | 504B | ||
| 20.46x | 4.99x | 12.38x | 2.64% | 367B | ||
| 106.52x | 5.95x | 25.12x | 2.33% | 360B | ||
| 21.18x | 5.54x | 13.63x | 2.88% | 288B | ||
| 21.7x | 4.38x | 12.55x | 2.01% | 258B | ||
| 27.46x | 7.06x | 12.64x | 2.33% | 234B | ||
| -45.63x | 6.99x | 27.07x | 2.11% | 194B | ||
| Average | 29.05x | 6.58x | 18.18x | 1.96% | 394.45B | |
| Weighted average by Cap. | 34.72x | 8.20x | 20.04x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EMCURE Stock
- Valuation Emcure Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















